These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19245916)

  • 1. Platelet-dense granule deficiency causes postoperative hemorrhage in patients receiving enoxaparin: a novel observation with dramatic clinical implications.
    Kligman MD; Zyromski NJ; McCullough DG; Gunning WT
    Am J Surg; 2009 Mar; 197(3):365-70. PubMed ID: 19245916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best Poster Award. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin.
    Kothari SN; Lambert PJ; Mathiason MA
    Am J Surg; 2007 Dec; 194(6):709-11. PubMed ID: 18005758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin.
    Hardy RG; Williams L; Dixon JM
    Br J Surg; 2008 Jul; 95(7):834-6. PubMed ID: 18425795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C; Omran H; Tripp C; Poetzsch B
    Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery.
    Hakki SI; Fareed J; Hoppensteadt DA; Abdullah H; Camblin J; Nasseri AF; Hamadeh O; Wright T
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):65-71. PubMed ID: 11190908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
    Koren-Michowitz M; Avni B; Michowitz Y; Moravski G; Efrati S; Golik A
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):299-302. PubMed ID: 15133781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B
    Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retroperitoneal bleed induced by enoxaparin therapy.
    Ernits M; Mohan PS; Fares LG; Hardy H
    Am Surg; 2005 May; 71(5):430-3. PubMed ID: 15986976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total hyphema following postoperative enoxaparin (Clexane).
    Sharan S; Painter G; Grigg JR
    Eye (Lond); 2005 Jul; 19(7):827-8. PubMed ID: 15359239
    [No Abstract]   [Full Text] [Related]  

  • 15. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery.
    Franchini M; Zugni C; Veneri D; Gandini G; Lippi G; Manzato F; Brazzarola P
    Haematologica; 2004 Nov; 89(11):1341-6. PubMed ID: 15531456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
    Robinson M; Healey JS; Eikelboom J; Schulman S; Morillo CA; Nair GM; Baranchuk A; Ribas S; Evans G; Connolly SJ; Turpie AG
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):378-82. PubMed ID: 19272069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter 3: use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin (Br J Surg 2008; 95: 834-836).
    Barry M
    Br J Surg; 2008 Nov; 95(11):1426-7; author reply 1427. PubMed ID: 18844278
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter 2: use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin (Br J Surg 2008; 95: 834-836).
    Hussain A; Mahmood H
    Br J Surg; 2008 Nov; 95(11):1426; author reply 1427. PubMed ID: 18844277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.